相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
L. Corey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Opioid Use Fueling HIV Transmission in an Urban Setting: An Outbreak of HIV Infection Among People Who Inject Drugs-Massachusetts, 2015-2018
Charles Alpren et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2020)
Implementation of a three-tiered approach to identify and characterize anti-drug antibodies raised against HIV-specific broadly neutralizing antibodies
Pranay Bharadwaj et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2020)
Optimization and qualification of a functional anti-drug antibody assay for HIV-1 bnAbs
Michael S. Seaman et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2020)
Broadly neutralizing antibodies for the treatment and prevention of HIV infection
Marina Caskey
CURRENT OPINION IN HIV AND AIDS (2020)
HIV outbreaks among people who inject drugs in Europe, North America, and Israel
Don C Des Jarlais et al.
Lancet HIV (2020)
Durable protection against repeated penile exposures to simian-human immunodeficiency virus by broadly neutralizing antibodies
David A. Garber et al.
NATURE COMMUNICATIONS (2020)
Characterization of Co-Formulated High-Concentration Broadly Neutralizing Anti-HIV-1 Monoclonal Antibodies for Subcutaneous Administration
Vaneet K. Sharma et al.
ANTIBODIES (2020)
PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland
Susan G. Sherman et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
HIV Diagnoses Among Persons Who Inject Drugs - Northeastern Massachusetts, 2015-2018
Kevin Cranston et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic
Marina Caskey et al.
NATURE MEDICINE (2019)
Outbreak of Human Immunodeficiency Virus Infection Among Heterosexual Persons Who Are Living Homeless and Inject Drugs — Seattle, Washington, 2018
Matthew R. Golden et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study
Yehuda Z. Cohen et al.
PLOS ONE (2019)
Injection Practices and Sexual Behaviors Among Persons with Diagnosed HIV Infection Who Inject Drugs - United States, 2015-2017
Sharoda Dasgupta et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions
Angela R. Bazzi et al.
BMC PUBLIC HEALTH (2019)
Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques
Matthew S. Parsons et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Elimination of HIV transmission through novel and established prevention strategies among people who inject drugs
Hudson Reddon et al.
LANCET HIV (2019)
MEDICAL PROVIDERS AND HARM REDUCTION VIEWS ON PRE-EXPOSURE PROPHYLAXIS FOR HIV PREVENTION AMONG PEOPLE WHO INJECT DRUGS
Rebecca B. Hershow et al.
AIDS EDUCATION AND PREVENTION (2019)
An Exploration of Factors Impacting Preexposure Prophylaxis Eligibility and Access Among Syringe Exchange Users
Alexis M. Roth et al.
SEXUALLY TRANSMITTED DISEASES (2018)
Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015
Dawn K. Smith et al.
ANNALS OF EPIDEMIOLOGY (2018)
A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infection
Rajeev Gautam et al.
NATURE MEDICINE (2018)
Recent progress in broadly neutralizing antibodies to HIV
Devin Sok et al.
NATURE IMMUNOLOGY (2018)
Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs
K. B. Biello et al.
HARM REDUCTION JOURNAL (2018)
Use of broadly neutralizing antibodies for HIV-1 prevention
Amarendra Pegu et al.
IMMUNOLOGICAL REVIEWS (2017)
Detailed Transmission Network Analysis of a Large Opiate-Driven Outbreak of HIV Infection In the United States
Ellsworth M. Campbell et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
Marina Caskey et al.
NATURE MEDICINE (2017)
Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection
Matthew S. Parsons et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review
Louisa Degenhardt et al.
LANCET GLOBAL HEALTH (2017)
Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir Study
Michael Martin et al.
LANCET HIV (2017)
Systemic and topical use of monoclonal antibodies to prevent the sexual transmission of HIV
Deborah J. Anderson et al.
AIDS (2017)
Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis
Andrea J. Low et al.
CLINICAL INFECTIOUS DISEASES (2016)
Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC
Irene Kuo et al.
DRUG AND ALCOHOL DEPENDENCE (2016)
County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States
Michelle M. Van Handel et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial
Sheena McCormack et al.
LANCET (2016)
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013
Louisa Degenhardt et al.
LANCET INFECTIOUS DISEASES (2016)
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
Johannes F. Scheid et al.
NATURE (2016)
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges
Rajeev Gautam et al.
NATURE (2016)
HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015
Philip J. Peters et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Marina Caskey et al.
NATURE (2015)
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques
Masashi Shingai et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
Kachit Choopanya et al.
LANCET (2013)
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies
Hugo Mouquet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Johannes F. Scheid et al.
SCIENCE (2011)
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men.
Robert M. Grant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges
Shambavi Subbarao et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
TW Baba et al.
NATURE MEDICINE (2000)
分享论文
